Prof Timothy IllidgeBSc PhD MRCP FRCR FRCPath

Professor of Targeted Therapy & Oncology

Affiliations:
Email:
Full contact details
ORCID: 0000-0003-3191-7324
View graph of relations

Overview

Professor of Targeted Therapy and Oncology, University of Manchester and Honorary Consultant in Clinical Oncology at Christie Hospital NHS Foundation Trust

Qualifications

BSc, PhD, MB BS, DRCOG, MRCP, FRCR, FRCPath

Memberships of committees and professional bodies

Fellowship Royal College of Radiologists

Membership Royal College of Physicians

Fellowship of Royal College of Pathologists

External positions

Steering committee, National Cancer Research Institute (NCRI)

1 Sep 2009 → …

Biology, Medicine and Health (BMH) Domains

Related information

Publications

Five-year results of brentuximab vedotin in patients with relapsed or refractory systemic anaplastic large cell lymphoma

Research output: Contribution to journal › Article

Akt inhibition improves long-term tumour control following radiotherapy by altering the microenvironment

Research output: Contribution to journal › Article

Fractionated radiation therapy stimulates anti-tumor immunity mediated by both resident and infiltrating polyclonal T-cell populations when combined with PD1 blockade

Research output: Contribution to journal › Article

View all (123)

Projects

NIHR Biomedical Research Centre: Cancer Advanced Radiotherapy Theme. (PROJECT)

Project: Research

Advanced Radiotherapies Technologies Network (ART-NET) (PROJECT)

Project: Research

Global Challenge Network + in Advanced Radiotherapy. (PROJECT)

Project: Research

View all (4)

Student Theses

PRE-CLINICAL EVALUATION OF THE NOVEL AKT INHIBITOR AZD5363 IN COMBINATION WITH RADIATION

UoM administered thesis: Phd

View all (1)

Prizes

Gold National Clinical Excellence Award

Prize: Prize (including medals and awards)

Royal College of Radiologists Gold Medal

Prize: Prize (including medals and awards)

View all prizes (2)